Palo Alto Investors LP - SUNESIS PHARMACEUTICALS INC ownership

SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 42 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
Palo Alto Investors LP ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$231,000
+59.3%
116,2460.0%0.01%
+50.0%
Q3 2020$145,000
-52.6%
116,246
-90.0%
0.01%
-55.6%
Q2 2020$306,000
-36.5%
1,162,4730.0%0.02%
-55.0%
Q1 2020$482,000
+22.6%
1,162,4730.0%0.04%
+81.8%
Q4 2019$393,000
-53.0%
1,162,4730.0%0.02%
-60.7%
Q3 2019$837,000
-0.9%
1,162,4730.0%0.06%
+36.6%
Q2 2019$845,000
-40.2%
1,162,4730.0%0.04%
-30.5%
Q1 2019$1,412,000
+192.3%
1,162,4730.0%0.06%
+126.9%
Q4 2018$483,000
-79.2%
1,162,4730.0%0.03%
-72.3%
Q3 2018$2,325,000
-5.6%
1,162,4730.0%0.09%
-4.1%
Q2 2018$2,464,000
-22.1%
1,162,4730.0%0.10%
-27.4%
Q1 2018$3,162,000
-26.3%
1,162,4730.0%0.14%
-27.0%
Q4 2017$4,290,000
+90.2%
1,162,4730.0%0.18%
+94.7%
Q3 2017$2,255,000
-28.2%
1,162,4730.0%0.10%
-35.4%
Q2 2017$3,139,000
-34.1%
1,162,4730.0%0.15%
-34.7%
Q1 2017$4,766,000
+13.3%
1,162,4730.0%0.22%
-6.2%
Q4 2016$4,208,000
-17.2%
1,162,4730.0%0.24%
-18.6%
Q3 2016$5,080,0001,162,4730.30%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
CAXTON CORP 8,134,926$3,375,0003.69%
Aisling Capital Management LP 10,100,000$4,190,0001.82%
Samsara BioCapital, LLC 5,938,215$2,464,0001.42%
Corriente Advisors, LLC 3,021,692$1,254,0001.35%
MPM BioImpact LLC 2,809,912$1,166,0000.71%
Burrage Capital Management LLC 682,586$280,0000.28%
Avidity Partners Management LP 4,310,000$1,788,0000.25%
BVF INC/IL 6,194,925$2,570,0000.24%
Nantahala Capital Management 9,566,844$3,969,0000.15%
Worth Venture Partners, LLC 362,330$150,0000.09%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders